Send to printer »

GEN Webinars: January 01, 1990

CRISPR/Cas9 Cell Therapeutics – The Next Generation of Cures

<p> The discovery of CRISPR/Cas9 as a simple and effective tool for targeted modification of cells has opened up new possibilities for gene or cell therapies. Join us to hear about strategies for using CRISPR/Cas9 for curing genetic diseases, e.g. sickle cell disease or HIV, its opportunities and challenges. In addition, we will discuss how CRISPR/Cas9 can impact next-generation disease model systems and drug screening, which might be relevant for combinational therapies.</p> <h3> Who Should Attend</h3> <ul> <li> Researchers working on gene or cell therapies</li> <li> Translational research scientists</li> <li> Clinical researchers</li> <li> Process development scientists and pilot-scale scientists</li> <li> Chief scientific officers and chief technical officers</li> <li> CMO scientists</li> </ul> <h3> You Will Learn About</h3> <ul> <li> Introduction to CRISPR/Cas9</li> <li> Application examples with focus on use for sickle cell disease</li> <li> Opportunities and challenges for the use of CRISPR/Cas9 in gene/cell therapeutic applications</li> <li> Use of CRISPR for next-generation disease model systems</li> <li> Non-viral transfer of CRISPR/Cas9 cargos and up-scaling of the transfection process</li> </ul>